Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents

Endoglin Regulates Cancer-Stromal Cell Interactions in Prostate Tumors

(2011) D. Romero et al.   CANCER RESEARCH

Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy

(2011) R Gardlik et al.   GENE THERAPY

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Antiangiogenic therapy: impact on invasion, disease progression and metastasis

(2011) John M. L. Ebos et al.   Nature Reviews Clinical Oncology

Antiangiogenic therapy, hypoxia and metastasis: risky liaisons, or not?

(2011) Katrien De Bock et al.   Nature Reviews Clinical Oncology

Transdifferentiation of glioblastoma cells into vascular endothelial cells

(2011) Y. Soda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

(2011) Olivier Keunen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Role of the TGF-β Coreceptor Endoglin in Cancer

(2011) Eduardo Pérez-Gómez et al.   TheScientificWorldJOURNAL

Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy?

(2010) Stanisław Szala et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy

(2010) Amir Abdollahi et al.   DRUG RESISTANCE UPDATES

Mechanisms of resistance to antiangiogenesis therapy

(2010) Faisal Azam et al.   EUROPEAN JOURNAL OF CANCER

DNA Vaccines: Developing New Strategies against Cancer

(2010) Daniela Fioretti et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

(2010) Lucia Ricci-Vitiani et al.   NATURE

Glioblastoma stem-like cells give rise to tumour endothelium

(2010) Rong Wang et al.   NATURE

Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma

(2010) E Pardali et al.   ONCOGENE

Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome

(2010) L A Henry et al.   ONCOGENE

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

(2009) John M.L. Ebos et al.   CANCER CELL

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

Natural killer cell is a major producer of interferon γ that is critical for the IL-12-induced anti-tumor effect in mice

(2009) Akio Uemura et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours

(2009) E. Fonsatti et al.   CARDIOVASCULAR RESEARCH

Enhancing Cancer Vaccine Efficacy via Modulation of the Tumor Microenvironment

(2009) M. L. Disis   CLINICAL CANCER RESEARCH

Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature

(2009) Shima Uneda et al.   INTERNATIONAL JOURNAL OF CANCER

Endoglin in angiogenesis and vascular diseases

(2008) Peter ten Dijke et al.   ANGIOGENESIS

Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy

(2008) N. A. Dallas et al.   CLINICAL CANCER RESEARCH

Immune surveillance: a balance between protumor and antitumor immunity

(2008) Suzanne Ostrand-Rosenberg   CURRENT OPINION IN GENETICS & DEVELOPMENT

Identification of an invasion and tumor-suppressing gene,Endoglin(ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma

(2008) Victor Chun Lam Wong et al.   INTERNATIONAL JOURNAL OF CANCER

Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice

(2008) Masanori Tsujie et al.   INTERNATIONAL JOURNAL OF CANCER